Mobile Old Site Home Daily Products Help Contact Us Your Account System Status
Sign-up for a FREE 30-day Stockwatch subscription and SEE NO ADS
09:52:28 EST Tue 24 Nov 2020
Enter Symbol
or Name
USA
CA



Forgot password?
Trouble logging in?
Login ID:
Password:
Save

Q:REGN - REGENERON PHARMACEUTICALS INC - http://www.regeneron.com09:52:28 EST
Sym-XBid - AskLastChg%ChVol$Vol#TrOpen-Hi-LoYear Hi-LoLast TrNewsDelay
REGN - Q0.1525.39·526.500.1526.54+2.930.651.226,5661,153522.59  526.54  522.10664.64  328.12509:33:00Nov 2115 min RT 2¢

Recent Trades - Last 10 of 1153
Time ETExPriceChangeVolume
09:33:10Q525.952.3438
09:33:10Q526.492.883
09:33:06Q525.9452.335100
09:33:04Q525.391.781
09:33:03Q525.391.7850
09:33:02Q525.72862.118650
09:33:02Q526.00492.394910
09:33:00Q526.492.8813
09:33:00Q525.391.785
09:32:56Q526.502.891

Sign-up for a FREE 30-day Stockwatch subscription and SEE NO ADS

Recent BulletinsNews ReleasesIn The NewsOther
Date ETSymbolTypeHeadline
2020-11-21 19:56U:REGNNews ReleaseRegeneron's REGEN-COV2 is First Antibody Cocktail for COVID-19 to Receive FDA Emergency Use Authorization
2020-11-16 07:00U:REGNNews ReleaseRegeneron Included on Dow Jones Sustainability World Index for Second Consecutive Year
2020-11-13 16:15U:REGNNews ReleaseRegeneron Announces Investor Conference Presentations
2020-11-05 06:30U:REGNNews ReleaseRegeneron Reports Third Quarter 2020 Financial and Operating Results
2020-11-02 10:00U:REGNNews Release2nd Annual Gabelli Funds – Columbia Business School Healthcare Symposium (Virtual) – Friday, November 13, 2020
2020-10-30 09:12U:REGNNews ReleaseREGN-COV2 Independent Data Monitoring Committee Recommends Holding Enrollment in Hospitalized Patients with High Oxygen Requirements and Continuing Enrollment in Patients with Low or No Oxygen Requirements
2020-10-29 14:32U:REGNNews ReleaseRegeneron Once Again Earns #1 Ranking in Science Magazine's Top Biopharma Companies to Work For
2020-10-29 07:00U:REGNNews ReleaseFDA Accepts for Priority Review Libtayo ® (cemiplimab-rwlc) for Advanced Non-small Cell Lung Cancer with PD-L1 Expression of =50%
2020-10-28 17:00U:REGNNews ReleaseRegeneron's COVID-19 Outpatient Trial Prospectively Demonstrates that REGN-COV2 Antibody Cocktail Significantly Reduced Virus Levels and Need for Further Medical Attention
2020-10-27 16:30U:REGNNews ReleaseRegeneron Announces Investor Conference Presentations